Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer

N/ACompletedNCT02381912

Herlev Hospital210 enrolled

Overview

The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.

Study Type

OBSERVATIONAL

Enrollment

210

Conditions

Urinary Bladder Neoplasms Sexual Dysfunction, Physiological Sexual Dysfunctions, Psychological Erectile Dysfunction Hematuria

Interventions

EORTC QLQ-C30 and EORTC BLS-24 questionnaireOTHER

Questionnaires answered at baseline and 4 months follow up.

Eligibility

Sex: ALLMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with primary hematuria, both gross and microscopic * Men and women older or equal to 40 years of age * Signed informed consent statement Exclusion Criteria: * Men and women younger than 40 years of age * Patients with recurrent hematuria and known causative disease * Already known urogenital cancer * Previous massive pelvic surgery or pelvic radiotherapy * TUR-P within the last 2 months * Participants diagnosed with tumors originating from the ureters, renal pelvis and kidney, and bladder tumors at T stage more than or equal to T1b.

Locations (1)

Herlev Hospital

Herlev, Denmark

Outcomes

Primary Outcomes

Change in sexual function

Change in sexual function measured by the "EORTC QLQ-BLS24 sexual functioning questions"

Time frame: 4 months

Secondary Outcomes

Change in erectile function

Change in erectile function measured by the Erection Hardness Scale

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.